$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018
Lloyd Price
JULY 5, 2018
The biggest deal of the year though, at least so far, was Takeda Pharmaceutical’s bid to acquire Shire Plc for $62.2 markets for Japan-based Takeda and Shire’s drugs will have easier access to markets in Japan. The deal will help open U.S.
40 
Let's personalize your content